3,4-dihydroxybenzohydroxamic acid has been researched along with Autoimmune Diseases of the Nervous System in 1 studies
Autoimmune Diseases of the Nervous System: Disorders caused by cellular or humoral immune responses primarily directed towards nervous system autoantigens. The immune response may be directed towards specific tissue components (e.g., myelin) and may be limited to the central nervous system (e.g., MULTIPLE SCLEROSIS) or the peripheral nervous system (e.g., GUILLAIN-BARRE SYNDROME).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clark, KC | 1 |
| Josephson, A | 1 |
| Benusa, SD | 1 |
| Hartley, RK | 1 |
| Baer, M | 1 |
| Thummala, S | 1 |
| Joslyn, M | 1 |
| Sword, BA | 1 |
| Elford, H | 1 |
| Oh, U | 1 |
| Dilsizoglu-Senol, A | 1 |
| Lubetzki, C | 1 |
| Davenne, M | 1 |
| DeVries, GH | 1 |
| Dupree, JL | 1 |
1 other study available for 3,4-dihydroxybenzohydroxamic acid and Autoimmune Diseases of the Nervous System
| Article | Year |
|---|---|
Compromised axon initial segment integrity in EAE is preceded by microglial reactivity and contact.
Topics: Animals; Animals, Genetically Modified; Autoimmune Diseases of the Nervous System; Axon Initial Segm | 2016 |